• Advertise
  • Contact Us
  • Write For Us
  • Our Team
Extraction Magazine
No Result
View All Result
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
No Result
View All Result
Extraction Magazine
No Result
View All Result
Home Industry News

Canopy Growth Locks Horns with GW Pharmaceuticals Over Patented Extraction Method

Colby McCoy by Colby McCoy
February 12, 2021
in Industry News
Canopy Growth Locks Horns with GW Pharmaceuticals Over Patented Extraction Method

Canopy Growth Corp. has filed a lawsuit against GW Pharmaceuticals, the producer of Epidiolex, for the usage of a patented cannabidiol (CBD) extraction method. Canopy alleges that GW has violated intellectual property rights.

Canopy argues that its proprietary CBD extraction method was purchased from German-based C3 Cannabinoid Compound Co. for $250 million in 2019.

READ ALSO

FECO vs RSO: What Extraction Operators Can Learn From Food and Supplement Manufacturing

Solventless Extraction Methods Explained: What Food and Supplement Manufacturing Can Teach Operators

According to Canopy, GW uses the same extraction method to produce Epidiolex, the first ever CBD-based drug to be approved by the U.S. Food and Drug Administration for treatment-resistant cases of epilepsy and seizures.

Plaintiff Canopy filed the patent infringement suit on December 22, 2020, the same day the US government approved their patent. While the company has refused to share details about the ongoing litigation, Canopy has said it does not aim to limit patient access to Epidiolex.

“GW has been monitoring the ’632 Patent family for over fourteen years,” Canopy stated, suggesting that GW has made ongoing efforts to acquire the patented extraction method from C3.

The extraction method in question involves carbon dioxide (CO2), which the ‘632 patent family reportedly covers. Specifically, the method relates to grinding cannabis or hemp then using supercritical CO2 followed by ethanol winterization. Adsorbents are also listed when certain end products are desired. According to Canopy, it is a “pioneering processes for producing an extract from cannabis plant matter containing CBD using carbon dioxide.”

Regardless of Canopy’s patent, GW remains confident it will emerge the victor in the litigation process.

“As a policy, we do not comment on any pending litigation except to say that based on our preliminary review of the complaint, we are confident in our position and will vigorously defend against this lawsuit,” GW Pharma told Marijuana Business Daily.

Photo courtesy of Bill Oxford, Unsplash

Related Posts

Botanical Extraction

FECO vs RSO: What Extraction Operators Can Learn From Food and Supplement Manufacturing

November 19, 2026
Botanical Extraction

Solventless Extraction Methods Explained: What Food and Supplement Manufacturing Can Teach Operators

November 18, 2026
Botanical Extraction

What Is Full Spectrum Extract? Lessons From Food, Pharma and Supplements for Extraction Operators

November 18, 2026
Botanical Extraction

Live Resin vs Live Sugar vs Live Rosin: What Food and Pharma Quality Systems Teach Extractors

November 16, 2026
Botanical Extraction

Top 10 Plants Used for Hydrosol Production, and the Quality Lessons Each One Teaches

November 15, 2026
Botanical Extraction

What Is Steam Distillation? Lessons From Food, Pharma and Supplements for Extraction Operators

November 15, 2026
Next Post
Isolation and Identification of Salvinorin A from Salvia divinorum

Isolation and Identification of Salvinorin A from Salvia divinorum

Sitemap

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.

No Result
View All Result
  • Industry News
  • Botanical Extraction
  • Medical Research
  • Medical Research
  • Glossary
  • Our Team
  • Write For Us

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.